News

Inside the FDA's plans to embrace AI agencywide
There could be an upside to incorporating AI for the FDA. Using AI to assist in final drug reviews would "represent a chance ...
Fierce Biotech8d
FDA will fully adopt generative AI by end of June, Martin Makary says
The Food and Drug Administration is going all in on artificial intelligence. | The Food and Drug Administration is going all ...
FDA says it will be 'aggressive' in adopting artificial intelligence in its labs
The Food and Drug Administration on Thursday announced an aggressive agency-wide Artificial intelligence adoption timeline ...
Fierce Biotech1d
Martin Makary outlines AI plans and the broader vision for his term as FDA commissioner
WASHINGTON, D.C.—FDA Commissioner Martin Makary, M.D., offered more details into the agency’s recently announced plans to ...
HealthLeaders Media5d
FDA's plan to roll out AI agencywide raises questions
The FDA is rolling out an aggressive plan to make generative AI a linchpin in its decision-making, part of a bid to get faster and leaner in evaluating drugs, foods, medical devices and diagnostic ...
Lantern Pharma outlines commercialization of radar AI modules and expects LP-184 trial enrollment completion by June 2025
Q1 2025 Management View CEO Panna Sharma stated that "the first quarter of 2025 represents a pivotal inflection point for ...
MassDevice1d
GE HealthCare launches AI-based 3D reconstruction solution
GE HealthCare (Nasdaq: GEHC) today announced the launch of its CleaRecon DL technology for enhancing CBCT imaging.
JD Supra9d
FDA animal testing phaseout urges AI-based trial alternatives, organoids, other “NAMs”
The U.S. Food and Drug Administration (FDA) recently announced it plans to phase out animal testing in the development of monoclonal ...
STAT8d
Risk factors for childhood high blood pressure
The Food and Drug Administration plans to rapidly roll out a generative AI model to assist scientific ... encourage careful testing before full adoption. The announcement spurred many questions.